Why things could get ugly over COVID-19 patents

In a time of crisis, access to appropriate pharmaceuticals is of paramount importance. At present there are six UK centres attempting to find an antiviral treatment for the COVID-19 virus.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Gilead sues US govt for breach of contract over antiviral patents

29 April 2020 Gilead has escalated its dispute with the US federal government by filing a new lawsuit accusing it of improperly filing for patents covering HIV drug Truvada.

Americas

World’s scientists working on nearly 80 COVID-19 vaccines

21 April 2020 A total of 79 vaccines and 155 drugs are currently being developed across the globe to combat COVID-19, according to statistics from the Austrian Institute for Health Technology Assessment.

Big Pharma

Canada authorises compulsory licences for COVID-19 shortfalls

27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.